Bispecific T-cell engager therapy for gastrointestinal cancers.

Saved in:
Bibliographic Details
Title: Bispecific T-cell engager therapy for gastrointestinal cancers.
Authors: Burton KA; Department of Medicine, University of Wisconsin, Madison, WI, USA., Metropulos AE; Indiana University School of Medicine, Gary, IN, USA., Kamath SD; Department of Medicine, Division of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA., Munshi HG; Department of Medicine, Division of Hematology and Oncology, Northwestern University, Chicago, IL, USA; The Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA; Jesse Brown VA Medical Center, Chicago, IL, USA., Principe DR; Department of Medicine, Division of Hematology and Oncology, Northwestern University, Chicago, IL, USA; The Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA. Electronic address: daniel.principe@northwestern.edu.
Source: Cancer letters [Cancer Lett] 2026 May 28; Vol. 646, pp. 218417. Date of Electronic Publication: 2026 Mar 09.
Publication Type: Journal Article; Review
Journal Info: Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1872-7980
DOI:10.1016/j.canlet.2026.218417